Over the past several years, Accelerate Diagnostics and our scientific collaborators have conducted numerous scientific studies supporting the exciting capabilities of our ID/AST System. Many of these studies resulted in posters presented at international conferences and peer-reviewed publications. We have conducted over 87,000 internal identification and susceptibility experiments across a panel of more than 20 of the most clinically prevalent species in sample types such as positive blood cultures and BALs. These studies demonstrated compelling performance versus reference and comparator methods, the results of which have been consistently duplicated by our clinical research partners. Below you will find links to some of these posters and publications.
These publications may include information from one or more organism/antimicrobial combinations that are research use only and not for use in diagnostic procedures.
Certain uses of devices included in these publications may not have been approved or cleared by the U.S. Food and Drug Administration or other regulatory bodies.
See product labeling for instructions for use, warnings, and limitations specific to each product and region.Okay, I understand. Show me the publications.
Real-World Impact of the Accelerate PhenoTest® BC Kit on patients with bloodstream infections in IOAS A Quasi-Experimental Multicenter Study
Clinical Infectious Diseases
Amira A Bhalodi1a, Shawn H MacVane1a, Bradley Ford2, Dilek Ince2, Patrick M Kinn2, Kelly M Percival2, Derek N Bremmer3, Dustin R Carr3, Thomas L Walsh3, Micah M Bhatti4, Samuel A Shelburne5, Romney M Humphries1* , Kaleb Wolfe5, Eric R Rosenbaum5, Ryan K Dare5, Johann Kolev6, Meghan Madhusudhan6, Michael A Ben-Aderet6, Margie A Morgan6 (1Accelerate Diagnostics, Inc., 2University of Iowa Hospitals and Clinics, 3Allegheny Health Network, Allegheny General Hospital, 4MD Anderson Cancer Center, 5University of Arkansas for Medical Sciences, 6Cedars-Sinai Medical Center, *Vanderbilt University Medical Center, acontributed equally)
Impact of the Accelerate PhenoTest® BC Kit on time to results for pathogens from bloodstream infections: IOAS (Improving Outcomes and Antibiotic Stewardship) study experience of 4 hospitals
A. Bhalodi, S. Macvane, R. Humphries, R. Dare, E. Rosenbaum, K. Wolfe, B. Ford, D. Ince, P. Kinn, K. Percival, D. Bremmer, D. Carr, T. Walsh, J. Kolev, M. Madhusudhan, M. Ben-Aderet, M. Morgan (University of Arkansas for Medical Sciences, The University of Iowa Hospitals and Clinics, , Allegheny Health Network, Cedars-Sinai Medical Center )
Evaluating the impact of the Accelerate PhenoTest® BC Kit on patients with bloodstream infections receiving ineffective empirical antibiotic treatment: IOAS study experience of 4 hospitals
S. Macvane, A. Bhalodi, R. Humphries, M. Ben-Aderet, J. Kolev, M. Madhusudhan, M. Morgan, R. Dare, E. Rosenbaum, K. Wolfe, D. Bremmer, D. Carr, T. Walsh, P. Kinn, K. Percival, D. Ince, B. Ford (Cedars-Sinai Medical Center, University of Arkansas for Medical Sciences, Allegheny Health Network, The University of Iowa Hospitals and Clinics)
Antimicrobial use in patients with bloodstream infections from 4 hospitals in the Improving Outcomes and Antibiotic Stewardship (IOAS) study: a quasi-experimental multi-centre study of the Accelerate PhenoTest® BC Kit
S. Macvane, A. Bhalodi, R. Humphries, M. Ben-Aderet, J. Kolev, M. Madhusudhan, M. Morgan, B. Ford, D. Ince, P. Kinn, K. Percival, D. Bremmer, D. Carr, T. Walsh, K. Wolfe, E. Rosenbaum, R. Dare (Cedars-Sinai Medical Center, The University of Iowa Hospitals and Clinics, Allegheny Health Network, University of Arkansas for Medical Sciences)
Evaluation of a Rapid Blood Culture Assay for Phenotypic Antimicrobial Susceptibility Testing of Gram-negative Bacteria on Antimicrobial Use in Children
World Microbe Forum 2021
Thao Truong, Irvin Ibarra Flores, Kanokporn Mongkolrattanothai, Jennifer Dien Bard (Children's Hospital Los Angeles)
Improving outcomes and antibiotic stewardship (IOAS) for patients with Gram-positive bloodstream infections through use of rapid testing: a quasi-experimental multicentre study of the Accelerate PhenoTest BC™ Kit
Journal of Antimicrobial Chemotherapy
Shawn H MacVane, Amira A Bhalodi, Ryan K Dare, Eric R Rosenbaum, Kaleb Wolfe, Bradley Ford, Dilek Ince, Patrick Kinn, Kelly M Percival, Romney M Humphries (University of Arkansas for Medical Sciences, University of Iowa)
Impact of Accelerate Pheno and BacT/ALERT VIRTUO on Clinical Processes and Outcomes in Patients with Sepsis and Concurrent Gram-Negative Bacteremia
Antimicrobial Agents and Chemotherapy
Faith Babowicz, Reid LaPlante, Colby Mitchell, J. Nicholas O’Donnell, Ellis Tobin, Mary George, Joseph J. Carreno (Albany Medical Center Hospital)
Impact of an Antimicrobial Stewardship Program-bundled initiative utilizing Accelerate Pheno™ system in the management of patients with aerobic Gram-negative bacilli bacteremia
Thomas L Walsh, Derek N Bremmer, Matthew A Moffa, Tamara L Trienski, Carley Buchanan, Kelly Stefano, Catharine Hand, Tricia Taylor, Karen Kasarda, Nathan R Shively, Nitin Bhanot, Nicholas Cheronis, Briana E DiSilvio, Christian Y Cho, Dustin R Carr (Allegheny Health Network, Allegheny General Hospital)
Clinical and economical improvements after introducing rapid identification of bacteria and early antibiotic susceptibility testing in sepsis and bloodstream infections. Results of the PHENOMENON study
GMS Infectious Diseases
Michael Wilke, Wolfgang Heinlein, Luis Stiefenhofer, Klaus-Friedrich Bodmann (Kliniken Nordoberpfalz AG)
Performance of anti-pseudomonal beta lactams on the Accelerate PhenoTest® BC kit against a collection of P. aeruginosa isolates
Journal of Clinical Microbiology
Aaron Sikorski , Alena Shamsheyeva, Dulini Gamage, Niels Oppermann, Amira Bhalodi, Romney Humphries (Accelerate Diagnostics, Inc.)